Дізнайтеся про найкращі ціни та клініки з лікування лейкемії (рака крові) у Італії у 2026 році

Italy hosts globally recognized leukemia centers like San Raffaele Research Hospital in Milan. These facilities hold IRCCS accreditation from the Italian Ministry of Health. They integrate high-volume clinical care with advanced hematology research to provide innovative stem cell therapies and CAR T-cell treatments.

• Expert leadership: Dr. Fabio Ciceri leads the hematology unit at San Raffaele.
• Specialized accreditation: IRCCS status identifies institutions combining medical assistance with intensive research.
• Advanced diagnostics: Centers provide cytogenetic studies and bone marrow biopsies for precise staging.
• Clinical trials: Patients access innovative cell and gene therapy trials for blood cancers.

Bookimed Expert Insight: San Raffaele stands out because it operates one of Europe's largest research hospitals. They performed the world’s first stem cell therapy for rare immune disorders. Our data shows it serves 300,000 patients yearly. This massive volume ensures doctors like Dr. Fabio Ciceri maintain unmatched expertise in complex blood disorders.

Patient Consensus: Patients emphasize that northern centers like San Raffaele offer the easiest access to experimental trials. One patient noted that getting a second opinion at these top clinics helped correct a previous misdiagnosis of leukemia.

Italy offers advanced hematology treatments including CAR T-cell therapy and specialized stem cell transplants. Research centers like San Raffaele utilize gene therapy and molecular diagnostics. Highly trained specialists treat complex leukemia cases within JCI or IRCCS-accredited research hospitals in Milan and Pavia.

• Cellular therapy: San Raffaele provides CAR T-cell therapy for relapsed B-cell leukemia cases.
• Gene expertise: The first ex vivo gene therapy for ADA-SCID was developed in Milan.
• Advanced diagnostics: Cytogenetic studies and extended blood analysis ensure high-precision leukemia staging.
• Precision imaging: Centers utilize AI-driven software for ultra-precise tumor imaging in six seconds.

Bookimed Expert Insight: Italian research hospitals serve over 300,000 patients yearly while maintaining IRCCS status. This designation confirms they combine direct clinical care with active research. Dr. Fabio Ciceri at San Raffaele has published over 180 papers on hematological cancers. This deep academic focus often grants patients earlier access to experimental protocols.

Patient Consensus: Patients note that CAR-T therapy has led to long-term remission when chemotherapy failed. Many emphasize that getting specialized second opinions in Milan can quickly clarify initial diagnosis errors.

Italy hosts globally recognized leukemia specialists within IRCCS-accredited research hospitals. These experts lead advancements in allogeneic transplants and gene therapies. Top hematologists practice in Milan and Rome. They hold prestigious leadership roles in European oncology networks and clinical trial groups.

• Prof. Fabio Ciceri: Head of hematology at San Raffaele with 35+ years experience.
• Dr. Jacopo Peccatori: Transplant division leader managing over 90 allogeneic procedures annually.
• Prof. Franco Locatelli: Elite Rome-based expert specializing in pediatric and adult leukemia.
• Prof. Robin Foà: Distinguished specialist in Rome focusing on chronic lymphocytic leukemia.

Bookimed Expert Insight: Data shows that San Raffaele performs over 52,000 operations annually and holds a unique IRCCS status. This designation means the clinic must combine patient care with active research. For leukemia patients, this provides direct access to the world’s first licensed stem cell therapies not found in standard hospitals.

Patient Consensus: Patients note that top Italian specialists often resolve complex misdiagnoses through advanced blood analysis. They emphasize traveling directly to high-volume centers in Milan for the highest level of competence.

During your first leukemia appointment in Italy, ask about personalized protocols like European LeukemiaNet guidelines and CAR T-cell therapy eligibility. Clarify timelines for bone marrow biopsies and specialized diagnostic tests. Confirm how doctors manage side effects and infections within the IRCCS-accredited research hospital framework.

• Available treatments: Ask if CAR T-cell therapy or specific Venetoclax combinations are available for your subtype.
• Clinical trials: Inquire about trial eligibility at major research centers like San Raffaele in Milan.
• Diagnostic timeline: Determine how quickly bone marrow biopsies and cytogenetic studies can be scheduled and reviewed.
• Expert credentials: Confirm if your hematologist, like Professor Dr. Fabio Ciceri, leads international clinical trials.

Bookimed Expert Insight: Italian IRCCS-accredited centers like San Raffaele combine clinical care with high-level research. These institutions perform over 52,000 operations annually and offer unique therapies, such as the world's first ADA-SCID stem cell treatment. If you are seeking advanced cell or gene therapy, prioritize hospitals with this dual research-clinical designation for the best access to experimental protocols.

Patient Consensus: Patients note that some initial consultations can feel brief, so it is vital to bring a translated list of questions and request a written summary. Many recommend confirming if the hospital provides interpreters or if a private one is needed for complex medical discussions.